RT @LupusEurope: 🔴 People with #lupus are twice as likely to develop cardiovascular disease as healthy people. 👀 Learn more about CV risk…

RT @LupusEurope: 🔴 People with #lupus are twice as likely to develop cardiovascular disease as healthy people. 👀 Learn more about CV risk…

RT @LupusEurope: 🔴 People with #lupus are twice as likely to develop cardiovascular disease as healthy people. 👀 Learn more about CV risk…

RT @LupusEurope: 🔴 People with #lupus are twice as likely to develop cardiovascular disease as healthy people. 👀 Learn more about CV risk…

RT @LupusEurope: 🔴 People with #lupus are twice as likely to develop cardiovascular disease as healthy people. 👀 Learn more about CV risk…

RT @LupusEurope: 🔴 People with #lupus are twice as likely to develop cardiovascular disease as healthy people. 👀 Learn more about CV risk…

RT @LupusEurope: 🔴 People with #lupus are twice as likely to develop cardiovascular disease as healthy people. 👀 Learn more about CV risk…

RT @LupusEurope: 🔴 People with #lupus are twice as likely to develop cardiovascular disease as healthy people. 👀 Learn more about CV risk…

RT @LupusEurope: 🔴 People with #lupus are twice as likely to develop cardiovascular disease as healthy people. 👀 Learn more about CV risk…

RT @LupusEurope: 🔴 People with #lupus are twice as likely to develop cardiovascular disease as healthy people. 👀 Learn more about CV risk…

🔴 People with #lupus are twice as likely to develop cardiovascular disease as healthy people. 👀 Learn more about CV risk management in RMDs with the @eular_org recommendations by @SavinoSciascia @Lupusdoc @ramos_casals et al. ➡️ ➡️ https://t.co/2osALoRzL1

RT @LupusEurope: 🔴 People with #lupus are twice as likely to develop cardiovascular disease as healthy people. 👀 Learn more about CV risk…

RT @LupusEurope: 🔴 People with #lupus are twice as likely to develop cardiovascular disease as healthy people. 👀 Learn more about CV risk…

🔴 People with #lupus are twice as likely to develop cardiovascular disease as healthy people. 👀 Learn more about CV risk management in RMDs with the @eular_org recommendations by @SavinoSciascia @Lupusdoc @ramos_casals et al.➡️ ➡️ https://t.co/Ol9pD2t36Y

RT @InternaHUCAB: Tras clasificación ➡️ recomendaciones específicas ⬇️ últimas recomendaciones 🔗https://t.co/Y6m5umkUBw https://t.co/Hsk…

Tras clasificación ➡️ recomendaciones específicas ⬇️ últimas recomendaciones 🔗https://t.co/Y6m5umkUBw https://t.co/HskuJV3AIo

🎯EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. #EMEU10DoT 👉read more: https://t.co/mNoOL2sZ5S…

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome https://t.co/4BP6a9lJuo

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome https://t.co/xdpTe3NxJZ

@eular_org @SavinoSciascia @MariaTektonidou @ramos_casals 👀 Puedes leer las recomendaciones @eular_org para el manejo del riesgo CV en pacientes con #ERyME, publicadas por @SavinoSciascia @MariaTektonidou @ramos_casals et al. en @ARD_BMJ, aquí: https://t.c

RT @ARD_BMJ: ❗ EULAR recommendations for #cardiovascular risk management in #rheumatic and musculoskeletal diseases, including systemic #lu…

RT @afosfolipido: @aadea2017 @eular_org Aunque las recomendaciones son "para ERyME, incluyendo #LES y #SAF ", sólo vamos a contaros las q a…

@aadea2017 @eular_org Aunque las recomendaciones son "para ERyME, incluyendo #LES y #SAF ", sólo vamos a contaros las q atañen al síndrome antifosfolípido. Podéis encontrar todas las recomendaciones @eular_org en la publicación original d @SavinoSciascia @

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @MariaTektonidou: Nice summary based on #aPL/APS presence in #lupus of our recently published #EULAR recommendations for #cardiovascular…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @LupusMadrid: La semana pasada, en el evento organizado por la @RevMedInterne, se habló sobre riesgo cardiovascular en enfermedades auto…

RT @LupusMadrid: La semana pasada, en el evento organizado por la @RevMedInterne, se habló sobre riesgo cardiovascular en enfermedades auto…

La semana pasada, en el evento organizado por la @RevMedInterne, se habló sobre riesgo cardiovascular en enfermedades autoinmunes. Esto es importante xq los pacientes de lupus tienen ⬆️riesgo de enfermedad cardiovascular. Puedes leer sobre ello aquí: https

Nice summary based on #aPL/APS presence in #lupus of our recently published #EULAR recommendations for #cardiovascular risk management in RMDs including #SLE and #APS

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @ZuccoNoel: Riesgo cardiovascular en enfermedades autoimmunes , incluidas las recomendaciones recientes @eular_org para el manejo del r…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

Riesgo cardiovascular en enfermedades autoimmunes , incluidas las recomendaciones recientes @eular_org para el manejo del riesgo cardiovascular en pacientes con #lupus o aPL/APS Enlace: https://t.co/Re0XA9BphN Gracias @Lupusreference

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

RT @Lupusreference: ❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org…

❤️ Nice talk about #cardiovascular risk in #autoimmune diseases & #Lupus at #SNFMI85, including the recent @eular_org recommendations for the management of #cardiovascular risk in patients with #lupus or aPL/APS 🎯 Link: https://t.co/AxsCpTXgcn https:/

RT @LupusEurope: People with #lupus are twice as likely to develop cardiovascular disease as healthy people. Learn more about CV risk mana…

RT @LupusEurope: People with #lupus are twice as likely to develop cardiovascular disease as healthy people. Learn more about CV risk mana…

RT @LupusEurope: People with #lupus are twice as likely to develop cardiovascular disease as healthy people. Learn more about CV risk mana…

People with #lupus are twice as likely to develop cardiovascular disease as healthy people. Learn more about CV risk management in RMDs with the @eular_org recommendations by @SavinoSciascia @Lupusdoc @ramos_casals et al. https://t.co/2osALoRzL1 #WorldHea

RT @AKronbichler: @nathalie_conrad @TheLancet If you look at current recommendations, the unmet need becomes obvious https://t.co/y7L9XMrf17

@nathalie_conrad @TheLancet If you look at current recommendations, the unmet need becomes obvious https://t.co/y7L9XMrf17

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

RT @EMEUNET: Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, inc…

@DGRh_Tweets @rheumadocs @jleipy

Have you read the #EULAR recommendations for #cardiovascular risk 💚 management in #rheumatic & #musculoskeletal diseases, including #lupus and antiphospholipid syndrome yet? Link to the full paper – https://t.co/MLeUPP8MZ9 @APLAR_org @ACRheum @AFLA

New @EULAR_org recommendations to guide clinical practice and future research for improving CVR management in rheumatic and musculoskeletal diseases. https://t.co/oCdlIfwYDM

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

RT @MariaTektonidou: Hopefully our task force work will help improve #cardiovascular health in #RMDs: #EULAR recommendations for cardiovasc…

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome | Annals of the Rheumatic Diseases https://t.co/WTDzjHzSxR

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

RT @ArmenYuri: EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus…

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome @YuliyaFedorchen @OlenaZimba @AlinaDIMA14 @dnd52298582 https://t.co/ohT6FDR2de

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome https://t.co/dgKU87GDaY

Important commentary on our "#EULAR Recommendations for #CVD management in #rheumatic diseases including #SLE and #APS" manuscript https://t.co/65J34xqHRq It's time for #Cardio-#Rheumatology collaboration.

RT @enriquecalvoA: ¡Buena noticia! Junto con otras patologías que se suman, entra también por fin la #gota en esta actualización de EULAR s…

¡Buena noticia! Junto con otras patologías que se suman, entra también por fin la #gota en esta actualización de EULAR sobre recomendaciones de manejo de RCV en enfermedades reumáticas y musculoesqueléticas. @eular_org @SEReumatologia https://t.co/DjUeOJY

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome - PubMed https://t.co/qu9WQz7FJF

RT @Lupusreference: ❤️ EULAR recommendations for the management of #cardiovascular risk in patients with #lupus or aPL/APS 🎯 Link: https://…